Monitoring of s protein maturation in the endoplasmic reticulum by calnexin is important for the infectivity of severe acute respiratory syndrome coronavirus

Journal of Virology

Volumn 86, Issue 21, 2012, Pages 11745-11753

  Fukushi, Masaya ^a,b   Yoshinaka, Yoshiyuki ^c   Matsuoka, Yusuke ^a   Hatakeyama, Seisuke ^a   Ishizaka, Yukihito ^a   Kirikae, Teruo ^a   Sasazuki, Takehiko ^a   Miyoshi Akiyama, Tohru ^a  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALNEXIN; CALRETICULIN; SMALL INTERFERING RNA; VITRONECTIN;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MOUSE; MUTATION; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; SARS CORONAVIRUS; SEQUENCE HOMOLOGY; ULTRACENTRIFUGATION; VIRUS ENTRY; VIRUS INFECTIVITY; VIRUS PARTICLE;

ANIMALS; CALNEXIN; CELL LINE; ENDOPLASMIC RETICULUM; GLYCOSYLATION; HUMANS; MEMBRANE GLYCOPROTEINS; MICE; PROTEIN BINDING; PROTEIN PROCESSING, POST-TRANSLATIONAL; SARS VIRUS; VIRAL ENVELOPE PROTEINS; VIRUS REPLICATION;

SARS CORONAVIRUS;

EID: 84869050218     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01250-12     Document Type: Article

References (49)

1. Arima H, Kinoshita T, Ibrahim HR, Azakami H, Kato A. 1998. Enhanced secretion of hydrophobic peptide fused lysozyme by the introduction of N-glycosylation signal and the disruption of calnexin gene in Saccharomyces cerevisiae. FEBS Lett. 440:89-92
2. Bedard K, Szabo E, Michalak M, Opas M. 2005. Cellular functions of endoplasmic reticulum chaperones calreticulin, calnexin, and ERp57. Int.Rev. Cytol. 245:91-121
3. Bergeron E, et al. 2005. Implication of proprotein convertases in the processing and spread of severe acute respiratory syndrome coronavirus.Biochem. Biophys. Res. Commun. 326:554-563
4. Beyene A, Basu A, Meyer K, Ray R. 2004. Influence of N-linked glycans on intracellular transport of hepatitis C virus E1 chimeric glycoprotein and its role in pseudotype virus infectivity. Virology 324:273-285
5. Cameron MJ, Bermejo-Martin JF, Danesh A, Muller MP, Kelvin DJ.2008. Human immunopathogenesis of severe acute respiratory syndrome (SARS). Virus Res. 133:13-19
6. Caramelo JJ, Parodi AJ. 2008. Getting in and out from calnexin/calreticulin cycles. J. Biol. Chem. 283:10221-10225
7. Chapel C, et al. 2006. Antiviral effect of alpha-glucosidase inhibitors on viral morphogenesis and binding properties of hepatitis C virus-like particles.J. Gen. Virol. 87:861- 871
8. Chen J, Subbarao K. 2007. The immunobiology of SARS. Annu. Rev.Immunol. 25:443-472
9. Chu VC, Whittaker GR. 2004. Influenza virus entry and infection require host cell N-linked glycoprotein. Proc. Natl. Acad. Sci. U.S.A. 101:18153-18158
10. Denzel A, et al. 2002. Early postnatal death and motor disorders in mice congenitally deficient in calnexin expression. Mol. Cell. Biol. 22:7398-7404
11. Drosten C, et al. 2003. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N. Engl. J. Med. 348:1967-1976
12. Dwek RA, Butters TD, Platt FM, Zitzmann N. 2002. Targeting glycosylation as a therapeutic approach. Nat. Rev. Drug Discov. 1:65-75
13. Eickmann M, et al. 2003. Phylogeny of the SARS coronavirus. Science 302:1504-1505
14. Follis KE, York J, Nunberg JH. 2006. Furin cleavage of the SARS coronavirus spike glycoprotein enhances cell-cell fusion but does not affect virion entry. Virology 350:358-369
15. Haga S, et al. 2008. Modulation of TNF-alpha-converting enzyme by the spike protein of SARS-CoV and ACE2 induces TNF-alpha production and facilitates viral entry. Proc. Natl. Acad. Sci. U.S.A. 105:7809-7814
16. Hammond C, Helenius A. 1994. Quality control in the secretory pathway:retention of a misfolded viral membrane glycoprotein involves cycling between the ER, intermediate compartment, and Golgi apparatus. J. Cell Biol. 126:41-52
17. Han DP, Lohani M, Cho MW. 2007. Specific asparagine-linked glycosylation sites are critical for DC-SIGN-and L-SIGN-mediated severe acute respiratory syndrome coronavirus entry. J. Virol. 81:12029-12039
18. Hebert DN, Molinari M. 2007. In and out of the ER: protein folding,quality control, degradation, and related human diseases. Physiol. Rev.87:1377-1408
19. Helenius A. 1994. How N-linked oligosaccharides affect glycoprotein folding in the endoplasmic reticulum. Mol. Biol. Cell 5:253-265
20. Helenius A, Aebi M. 2004. Roles of N-linked glycans in the endoplasmic reticulum. Annu. Rev. Biochem. 73:1019-1049
21. Ishida I, et al. 2002. Production of human monoclonal and polyclonal antibodies in TransChromo animals. Cloning Stem Cells 4:91-102
22. Jeffers SA, et al. 2004. CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus. Proc. Natl. Acad. Sci. U.S.A. 101:15748-15753
23. Ksiazek TG, et al. 2003. A novel coronavirus associated with severe acute respiratory syndrome. N. Engl. J. Med. 348:1953-1966
24. Kuba K, et al. 2005. A crucial role of angiotensin converting enzyme 2(ACE2) in SARS coronavirus-induced lung injury. Nat. Med. 11:875-879
25. Lakkaraju AK, et al. 2012. Palmitoylated calnexin is a key component of the ribosome-translocon complex. EMBO J. 31:1823-1835
26. Li F, Li W, Farzan M, Harrison SC. 2005. Structure of SARS coronavirus spike receptor-binding domain complexed with receptor. Science 309:1864-1868
27. Li W, et al. 2003. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426:450-454
28. Liu S, et al. 2004. Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors. Lancet 363:938-947
29. Maginnis MS, Haley SA, Gee GV, Atwood WJ. 2010. Role of N-linked glycosylation of the 5-HT2A receptor in JC virus infection. J. Virol. 84:9677-9684
30. Marra MA, et al. 2003. The Genome sequence of the SARS-associated coronavirus. Science 300:1399-1404
31. Mehta A, Zitzmann N, Rudd PM, Block TM, Dwek RA. 1998. Alphaglucosidase inhibitors as potential broad based anti-viral agents. FEBS Lett. 430:17-22
32. Miyoshi-Akiyama T, et al. 2011. Fully human monoclonal antibody directed to proteolytic cleavage site in severe acute respiratory syndrome (SARS) coronavirus S protein neutralizes the virus in a rhesus macaque SARS model. J. Infect. Dis. 203:1574-1581
33. Moore MJ, et al. 2004. Retroviruses pseudotyped with the severe acute respiratory syndrome coronavirus spike protein efficiently infect cells expressing angiotensin-converting enzyme 2. J. Virol. 78:10628-10635
34. Moremen KW, Tiemeyer M, Nairn AV. 2012. Vertebrate protein glycosylation:diversity, synthesis and function. Nat. Rev. Mol. Cell Biol. 13:448-462
35. Oda Y, Hosokawa N, Wada I, Nagata K. 2003. EDEM as an acceptor of terminally misfolded glycoproteins released from calnexin. Science 299:1394-1397
36. Parlati F, Dominguez M, Bergeron JJ, Thomas DY. 1995. Saccharomyces cerevisiae CNE1 encodes an endoplasmic reticulum (ER) membrane protein with sequence similarity to calnexin and calreticulin and functions as a constituent of the ER quality control apparatus. J. Biol. Chem. 270:244-253
37. Peiris JS, et al. 2003. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 361:1319-1325
38. Prabakaran P, Xiao X, Dimitrov DS. 2004. A model of the ACE2 structure and function as a SARS-CoV receptor. Biochem. Biophys. Res. Commun.314:235-241
39. 39. Ritchie G, et al. 2010. Identification of N-linked carbohydrates from severe acute respiratory syndrome (SARS) spike glycoprotein. Virology 399:257-269
40. Rota PA, et al. 2003. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 300:1394-1399
41. Sayce AC, Miller JL, Zitzmann N. 2010. Targeting a host process as an antiviral approach against dengue virus. Trends Microbiol. 18:323-330
42. 42. Shichijo S, et al. 2004. Assessment of synthetic peptides of severe acute respiratory syndrome coronavirus recognized by long-lasting immunity.Tissue Antigens 64:600-607
43. Simmons G, et al. 2004. Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoproteinmediated viral entry. Proc. Natl. Acad. Sci. U.S.A. 101:4240-4245
44. Wada I, et al. 1991. SSR alpha and associated calnexin are major calcium binding proteins of the endoplasmic reticulum membrane. J. Biol. Chem.266:19599-19610
45. Wong SK, Li W, Moore MJ, Choe H, Farzan M. 2004. A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensinconverting enzyme 2. J. Biol. Chem. 279:3197-3201
46. Xiao X, Chakraborti S, Dimitrov AS, Gramatikoff K, Dimitrov DS.2003. The SARS-CoV S glycoprotein: expression and functional characterization.Biochem. Biophys. Res. Commun. 312:1159-1164
47. Yang ZY, et al. 2004. pH-dependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN. J. Virol. 78:5642-5650
48. Zhou Y, et al. 2010. A single asparagine-linked glycosylation site of the severe acute respiratory syndrome coronavirus spike glycoprotein facilitates inhibition by mannose-binding lectin through multiple mechanisms.J. Virol. 84:8753-8764
49. Zitzmann N, et al. 1999. Imino sugars inhibit the formation and secretion of bovine viral diarrhea virus, a pestivirus model of hepatitis C virus:implications for the development of broad spectrum anti-hepatitis virus agents. Proc. Natl. Acad. Sci. U.S.A. 96:11878-11882